Literature DB >> 25784678

Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma.

Dunja Schneider1, Marcus Dühren-von Minden2, Alabbas Alkhatib2, Corinna Setz2, Cornelis A M van Bergen3, Marco Benkißer-Petersen4, Isabel Wilhelm5, Sarah Villringer6, Sergey Krysov7, Graham Packham7, Katja Zirlik4, Winfried Römer5, Christian Buske8, Freda K Stevenson7, Hendrik Veelken3, Hassan Jumaa9.   

Abstract

B-cell antigen receptor (BCR) expression is a key feature of most B-cell lymphomas, but the mechanisms of BCR signal induction and the involvement of autoantigen recognition remain unclear. In follicular lymphoma (FL) B cells, BCR expression is retained despite a chromosomal translocation that links the antiapoptotic gene BCL2 to the regulatory elements of immunoglobulin genes, thereby disrupting 1 heavy-chain allele. A remarkable feature of FL-BCRs is the acquisition of potential N-glycosylation sites during somatic hypermutation. The introduced glycans carry mannose termini, which create potential novel binding sites for mannose-specific lectins. Here, we investigated the effect of N-linked variable-region glycosylation for BCR interaction with cognate antigen and with lectins of different origins. N-glycans were found to severely impair BCR specificity and affinity to the initial cognate antigen. In addition, we found that lectins from Pseudomonas aeruginosa and Burkholderia cenocepacia bind and stimulate FL cells. Human exposure to these bacteria can occur by contact with soil and water. In addition, they represent opportunistic pathogens in susceptible hosts. Understanding the role of bacterial lectins might elucidate the pathogenesis of FL and establish novel therapeutic approaches.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25784678      PMCID: PMC4482265          DOI: 10.1182/blood-2014-11-609404

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta.

Authors:  Roberta Pelanda; Uschi Braun; Elias Hobeika; Michel C Nussenzweig; Michael Reth
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

2.  Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells.

Authors:  Fabian Köhler; Eva Hug; Cathrin Eschbach; Sonja Meixlsperger; Elias Hobeika; Juliane Kofer; Hedda Wardemann; Hassan Jumaa
Journal:  Immunity       Date:  2008-12-11       Impact factor: 31.745

3.  Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.

Authors:  M Reth; G J Hämmerling; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

4.  N-linked glycosylation selectively regulates autonomous precursor BCR function.

Authors:  Rudolf Ubelhart; Martina P Bach; Cathrin Eschbach; Thomas Wossning; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

5.  Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.

Authors:  Neta S Zuckerman; Katy J McCann; Christian H Ottensmeier; Michal Barak; Gitit Shahaf; Hanna Edelman; Deborah Dunn-Walters; Roshini S Abraham; Freda K Stevenson; Ramit Mehr
Journal:  Int Immunol       Date:  2010-11-08       Impact factor: 4.823

6.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Authors:  Pedro Farinha; Hamid Masoudi; Brian F Skinnider; Karey Shumansky; John J Spinelli; Karamjit Gill; Richard Klasa; Nicolas Voss; Joseph M Connors; Randy D Gascoyne
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

Review 7.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

Authors:  Ruxana T Sadikot; Timothy S Blackwell; John W Christman; Alice S Prince
Journal:  Am J Respir Crit Care Med       Date:  2005-02-01       Impact factor: 21.405

Review 8.  N-linked protein glycosylation in the ER.

Authors:  Markus Aebi
Journal:  Biochim Biophys Acta       Date:  2013-04-10

9.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

10.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

Authors:  Zahra Sabouri; Peter Schofield; Keisuke Horikawa; Emily Spierings; David Kipling; Katrina L Randall; David Langley; Brendan Roome; Rodrigo Vazquez-Lombardi; Romain Rouet; Jana Hermes; Tyani D Chan; Robert Brink; Deborah K Dunn-Walters; Daniel Christ; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

View more
  30 in total

Review 1.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

2.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

3.  A study of the possible role of Fab-glycosylated IgG in tumor immunity.

Authors:  Qian Xu; Xiaodong Deng; Biying Zhang; Chanyuan Zhao; Tao Huang; Yimin Zhang; Zhiming Chen; Jiang Gu
Journal:  Cancer Immunol Immunother       Date:  2021-01-03       Impact factor: 6.968

Review 4.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

5.  Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.

Authors:  Fleur S van de Bovenkamp; Ninotska I L Derksen; Pleuni Ooijevaar-de Heer; Karin A van Schie; Simone Kruithof; Magdalena A Berkowska; C Ellen van der Schoot; Hanna IJspeert; Mirjam van der Burg; Ann Gils; Lise Hafkenscheid; René E M Toes; Yoann Rombouts; Rosina Plomp; Manfred Wuhrer; S Marieke van Ham; Gestur Vidarsson; Theo Rispens
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

6.  IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Authors:  Mariette Odabashian; Emanuela Carlotti; Shamzah Araf; Jessica Okosun; Filomena Spada; John G Gribben; Francesco Forconi; Freda K Stevenson; Mariarita Calaminici; Sergey Krysov
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

Review 7.  Follicular lymphoma: are we ready for a risk-adapted approach?

Authors:  Brad S Kahl
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  CACTUS: integrating clonal architecture with genomic clustering and transcriptome profiling of single tumor cells.

Authors:  Shadi Darvish Shafighi; Szymon M Kiełbasa; Cornelis A M van Bergen; Ewa Szczurek; Julieta Sepúlveda-Yáñez; Ramin Monajemi; Davy Cats; Hailiang Mei; Roberta Menafra; Susan Kloet; Hendrik Veelken
Journal:  Genome Med       Date:  2021-03-24       Impact factor: 11.117

9.  DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.

Authors:  Beatriz Valle-Argos; Giorgia Chiodin; Dean J Bryant; Joe Taylor; Elizabeth Lemm; Patrick J Duriez; Philip J Rock; Jonathan C Strefford; Francesco Forconi; Richard W Burack; Graham Packham; Freda K Stevenson
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

10.  Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.

Authors:  Giorgia Chiodin; Joel D Allen; Dean J Bryant; Philip Rock; Enrica A Martino; Beatriz Valle-Argos; Patrick J Duriez; Yasunori Watanabe; Isla Henderson; James S Blachly; Katy J McCann; Jonathan C Strefford; Graham Packham; Teunis B H Geijtenbeek; Carl G Figdor; George W Wright; Louis M Staudt; Richard Burack; Thomas A Bowden; Max Crispin; Freda K Stevenson; Francesco Forconi
Journal:  Blood       Date:  2021-10-28       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.